biotechnology products into India. Sandor has been the first company to bring “Point of Care” concept to the Indian ICU in 1996 by launch of i-stat, a state of the art product for emergency monitoring of patients.

The company started as a sales, marketing and distribution company and over time evolved as a nationwide distribution, sales and marketing company by 2008 when Genzyme launched their operations in India. It can today boast of a national level distribution network with 21CFR compliant cold chain facilities covering most of Indian states. Our efficient and compliant 20 branch distribution network supports drug and device manufacturers launch products with ready access to more than 3000 hospitals across India. The company today has more than 180 vendor registrations in Government and private Institutions making it the only partner for foreign or domestic manufacturers to bring their products to hospitals at the most economical costs while maintaining the highest ethical standards.

The company has over time developed a strong sales and marketing team which is helping it launch own branded products in select therapeutic area like Critical Care, Nephrology and Transplantation and Pain Management. Our strong presence in Government Institutions has ensured direct sales to all users without help of any sub dealer or liaison agents. The company also provides complete regulatory support to partners and has in-house pharmacovigilance function besides having a strong custom clearing department.

A firm foothold in the Indian Hospital procurement system has made Sandor a partner of choice for any new launch of medical drugs, devices and equipment in the Indian Hospital System.